Loading the security overview…
Where the tokens are
Standardised from the company’s filings, newest period first, labelled with the company’s own fiscal calendar. A line the company does not report is left off rather than shown as zero; margins and free cash flow are worked out here, and only where every input is present.
| Line item | Q2 FY262026-06-30 | Q1 FY262026-03-31 | Q4 FY252025-12-31 | Q3 FY252025-09-30 | Q2 FY252025-06-30 | Q1 FY252025-03-31 | Q4 FY242024-12-31 | Q3 FY242024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.89B | $2.77B | $2.87B | $2.51B | $2.44B | $2.25B | $2.41B | $2.04B |
| Cost of revenue | $931.90M | $940.30M | $961.90M | $842.70M | $822.10M | $795.70M | $771.30M | $664.20M |
| Gross profit | $1.96B | $1.83B | $1.90B | $1.66B | $1.62B | $1.46B | $1.64B | $1.37B |
| Gross margin | 67.8% | 66.1% | 66.4% | 66.4% | 66.3% | 64.7% | 68.0% | 67.4% |
| Research and development | $370.60M | $361.90M | $352.90M | $329.40M | $313.30M | $316.20M | $294.70M | $286.00M |
| Selling, general and administrative | $617.90M | $613.30M | $687.10M | $573.30M | $561.20M | $563.40M | $612.60M | $510.60M |
| Operating expenses | $988.50M | $975.20M | $1.04B | $902.70M | $874.50M | $879.60M | $907.30M | $796.60M |
| Operating income | $971.90M | $855.30M | $864.30M | $759.70M | $743.40M | $578.10M | $734.90M | $577.30M |
| Operating margin | 33.6% | 30.9% | 30.2% | 30.3% | 30.5% | 25.7% | 30.4% | 28.3% |
| EBITDA | $1.01B | $876.40M | $1.50B | $772.60M | $755.70M | $590.20M | $1.19B | $590.20M |
| Interest income | $82.70M | $85.10M | $0 | — | $88.70M | $90.40M | $0 | — |
| Income before taxes | $1.05B | $940.40M | $955.60M | $855.20M | $832.10M | $668.50M | $809.80M | $671.00M |
| Income taxes | $231.40M | $114.40M | $156.10M | $146.00M | $167.90M | −$35.20M | $121.80M | $100.40M |
| Net income | $823.20M | $826.00M | $799.50M | $709.20M | $664.20M | $703.70M | $688.00M | $570.60M |
| Net margin | 28.5% | 29.8% | 27.9% | 28.3% | 27.2% | 31.2% | 28.5% | 28.0% |
| EPS, basic | $2.31 | $2.31 | $2.24 | $1.98 | $1.84 | $1.95 | $1.92 | $1.59 |
| EPS, diluted | $2.29 | $2.28 | $2.21 | $1.95 | $1.81 | $1.92 | $1.88 | $1.56 |
| Diluted shares | 357.30M | 359.80M | 360.30M | 361.80M | 364.10M | 364.60M | 363.80M | 362.70M |
Figures describe Intuitive Surgical shares, not any token. As of Jul 21, 2026, from Massive's standardised financials. The company reports these figures; a token's issuer holds the shares and reports nothing of its own here.